Synchronized cycles of bacterial lysis for in vivo delivery
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The widespread view of bacteria as strictly pathogenic has given way to an appreciation of the prevalence of some beneficial microbes within the human body. It is perhaps inevitable that some bacteria would evolve to preferentially grow in environments that harbor disease and thus provide a natural platform for the development of engineered therapies. Such therapies could benefit from bacteria that are programmed to limit bacterial growth while continually producing and releasing cytotoxic agents in situ. Here we engineer a clinically relevant bacterium to lyse synchronously ata threshold population density and to release genetically encoded cargo. Following quorum lysis, a small number of surviving bacteria reseed the growing population, thus leading to pulsatile delivery cycles. We used microfluidic devices to characterize the engineered lysis strain and we demonstrate its potential as a drug delivery platform via co-culture with human cancer cells in vitro. Asa proof of principle, we tracked the bacterial population dynamics in ectopic syngeneic colorectal tumours in mice via a luminescent reporter. The lysis strain exhibits pulsatile population dynamics in vivo, with mean bacterial luminescence that remained two orders of magnitude lower than an unmodified strain. Finally, guided by previous findings that certain bacteria can enhance the efficacy of standard therapies, we orally administered the lysis strain alone or in combination with a clinical chemotherapeutic to a syngeneic mouse transplantation model of hepatic colorectal metastases. We found that the combination of both circuit-engineered bacteria and chemotherapy leads to a notable reduction of tumour activity along with a marked survival benefit over either therapy alone.Our approach establishes a methodology for leveraging the tools of synthetic biology to exploit the natural propensity for certain bacteria to colonize disease sites.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An interesting general approach implements engineered bacterial lysis, which enables antitumor protein production or release only when a predefined population density of bacteria is reached (154–157).”
From The microbiome and human cancer (2021) · cites this paper as [155]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The human microbiome: at the interface of health and disease
Cho, I., & Blaser, M. J. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3182 · Cited by 3,449
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
Davila, M. L., Riviere, I., Wang, X., Bartido, S., Park, J., Curran, K., Chung, S. S., Stefanski, J., Borquez-Ojeda, O., Olszewska, M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008226 · Cited by 2,476
Garrett, W. S. (2015) · Science · doi:10.1126/science.aaa4972 · Cited by 1,404
A synchronized quorum of genetic clocks
Danino, T., Mondragón-Palomino, O., Tsimring, L., & Hasty, J. (2010) · Nature · doi:10.1038/nature08753 · Cited by 992
Self-citationLeone, V., Gibbons, S. M., Martinez, K., Hutchison, A. L., Huang, E. Y., Cham, C. M., Pierre, J. F., Heneghan, A. F., Nadimpalli, A., Hubert, N., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.03.006 · Cited by 911
Engineering the perfect (bacterial) cancer therapy
Forbes, N. S. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2934 · Cited by 905 · cited 1×
“Thus a synergistic effect may arise when bacteria are used to deliver drugs to the necrotic core of a tumor, while standard chemotherapy is used for the vascularized regions 11,26 .”
BackgroundCombination bacteriolytic therapy for the treatment of experimental tumors
Dang, L. H., Bettegowda, C., Huso, D. L., Kinzler, K. W., & Vogelstein, B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251543698 · Cited by 563
Microbial Dysbiosis Is Associated with Human Breast Cancer
Xuan, C., Shamonki, J. M., Chung, A., DiNome, M. L., Chung, M., Sieling, P. A., & Lee, D. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0083744 · Cited by 543
Tumor-targeted Salmonella as a novel anticancer vector.
Pawelek, J. M., Low, K. B., & Bermudes, D. G. (1997) · PubMed · Cited by 527
Programmable probiotics for detection of cancer in urine
Danino, T., Prindle, A., Kwong, G. A., Skalak, M., Li, H., Allen, K., Hasty, J., & Bhatia, S. N. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa3519 · Cited by 467
Self-citation
Cited by
Items 601–700 of 782
Oncolytic Probiotics with Molecular Pili for Solid Tumor Therapy
Ge, H., Ding, C., Yang, X., Gao, S., Yang, C., Hou, Y., Wang, H., Bian, L., Zhong, H., Qu, Y., et al. (2026) · Advanced Science · doi:10.1002/advs.202517989 · Cited by 2
Harnessing engineered bacteria for revolutionizing cancer immunotherapy
Zhou, K., Cao, L., Luo, H.-Y., Wang, K.-N., Song, Z., & Bu, L. (2026) · Advanced Composites and Hybrid Materials · doi:10.1007/s42114-026-01664-3 · Cited by 2
Recent advances in acoustic cavitation-inducible materials for cancer sonotheranostics
Park, J. Y., Kang, J., Kwon, M., Jeong, Y. J., Ju, H., Heo, E.-J., Lee, C., Lee, J. H., Byun, H., Shin, H., et al. (2026) · Nanoscale · doi:10.1039/d5nr05210f · Cited by 2
Zhang, T., Yang, J., Cheng, G., Meng, F., Li, Y., Wang, J., Li, L., Bi, S., Chen, X., & Liu, Y. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124148 · Cited by 3
Bibliometric analysis of genetically engineered bacteria in tumor therapy
Zhu, Y., Yin, Y., Li, Y., Wang, Q., Chen, Y., Gu, K., Yang, R., Zhou, M., & Chen, D. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1794032 · Cited by 3
Jia, X., Xu, Y., Liu, X., Ye, M., Wang, F., Yang, X., Gao, X., Yu, J., & Liu, W. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114945 · Cited by 2
Yang, J. H., & Bashor, C. J. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115883 · Cited by 4
Pharmaco-microdynamics (PMD): Redefining dose, exposure, and control for living drug carriers
Abdullah, M., Jayadevan, K., Therayil, A., Kumaraguruparan, N., Kavyasree, P. K. V., Dilna, P., & Faiza, A. (2026) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2026.06.002 · Cited by 2
Spatial Frequency-Based Characterization of Disturbance Rejection in Molecular Communication Systems
Kotsuka, T., & Hori, Y. (2021) · IEEE Transactions on Molecular Biological and Multi-Scale Communications · doi:10.1109/tmbmc.2021.3083726 · Cited by 2
Ge, C., Run, S., Jia, H., & Tian, P. (2022) · Annals of Microbiology · doi:10.1186/s13213-022-01663-x · Cited by 2
Microbiome therapeutics for the cancer management
Punetha, A., & Punetha, A. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99336-4.00012-4 · Cited by 2
Generating Shigella that internalize into glioblastoma cells
Shipley, A., Frampton, G. A., Davies, B. W., & Umlauf, B. J. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1229747 · Cited by 2
Liang, L., Ye, Z., Wu, J., Lu, H., Liu, W., Meng, L., Li, Y., & Huang, H. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.153977 · Cited by 2
Almansour, M. A., Aldosary, M. S., Almegbel, M. T., Alsubaie, S. A., & Alzahrani, A. M. (2023) · International Journal of Health Sciences · doi:10.53730/ijhs.v7ns1.15041 · Cited by 3
Effects of asymmetric rates and impulse interference in Rock-Paper-Scissors games
Pei, K., Pei, Y., & Li, C. (2024) · Physica D Nonlinear Phenomena · doi:10.1016/j.physd.2024.134384 · Cited by 2
Beneficial Probiotics with New Cancer Therapies for Improved Treatment of Hepatocellular Carcinoma
Nakashima, M., Fukumoto, A., & Matsuda, S. (2025) · Diseases · doi:10.3390/diseases13040111 · Cited by 3
Host Evolution Improves Genetic Circuit Function in Complex Growth Environments
Zhang, J. T., Lezia, A., Emmanuele, P., Wu, M., Olson, E. C., Somani, A., Feist, A. M., & Hasty, J. (2025) · ACS Synthetic Biology · doi:10.1021/acssynbio.5c00168 · Cited by 4
Self-citationProbiotic-derived microcarriers enhance the oral bioavailability of poorly absorbed anticancer drugs
Kim, H., Lee, S.-S., Kim, Y., Jang, K., Kim, S., Hwang, I., & Chung, D. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125799 · Cited by 2
Can a Nanoparticle That Mimics Salmonella Effectively Combat Tumor Chemotherapy resistance?
Mercado–Lubo, R., & McCormick, B. A. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0005 · Cited by 2
Shnawa, I. M. S. A. W. (2017) · International Journal of Vaccines and Immune System · doi:10.25141/2475-6326-2017-2.0013 · Cited by 2
Kotsuka, T., & Hori, Y. (2019) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2019.12.237 · Cited by 2
Opportunities for Single‐Cell Sequencing in Synthetic Biology
Wollny, D. (2020) · ChemSystemsChem · doi:10.1002/syst.202000016 · Cited by 1
Synthetic criticality in cellular brains
Solé, R. V., Pueyo, N. C., Guillamon, A., Maull, V., Pla, J., Sardanyés, J., & Vidiella, B. (2021) · Journal of Physics Complexity · doi:10.1088/2632-072x/ac35b3 · Cited by 3
Engineered E. coli for the targeted deposition of therapeutic payloads to sites of diseasePreprint
Lynch, J. P., González-Prieto, C., Reeves, A. Z., Powale, U., Godbole, N. P., Tremblay, J. M., Schmidt, F. I., Ploegh, H. L., Glickman, J. N., Leong, J. M., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1233122/v1 · Cited by 2
Londhe, V. Y., & Bhadale, R. S. (2022) · Wiley eBooks · doi:10.1002/9781119558026.ch12 · Cited by 2
Exploring alternative quorum sensing model structures and quorum quenching strategiesPreprint
Cimolato, C., Bellato, M., Selvaggio, G., Marchetti, L., Giordano, G., & Luca Schenato, B. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.07.548074 · Cited by 2
CIMT 2024: Report on the 21st Annual Meeting of the Association for Cancer Immunotherapy
Ahrberg, Y., Dallmann, J., Freitag, J., Hassan, A., Jung, C., Kiefer, J., Muralidharan, A. M., Peter, M., & Beck, J. D. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2381925 · Cited by 3
Tumor-specific antibodies elicited by engineered bacteria promote bladder cancer immunotherapyPreprint
Rouanne, M., Chen, N., Mariuzza, D. L., Li, F., Santos, K. D. L., Savage, T. M., Vincent, R. L., Mendelsohn, C. L., Danino, T., & Arpaia, N. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.24.620122 · Cited by 2
Self-citationGodonu, S. S. (2025) · Preprints.org · doi:10.20944/preprints202507.0181.v1 · Cited by 2
Bio-inspired nanoparticles as drug delivery vectors
Gagliardi, M., & Cecchini, M. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820757-4.00002-8 · Cited by 1
Singh, R. P., Kolton, M., Boker, M., David, N. B., Green, S. J., Helman, A., Tirosh, O., & Hayouka, Z. (2022) · Exploration of Digestive Diseases · doi:10.37349/edd.2022.00009 · Cited by 1
Phenotypic Patterning through Copy Number Adaptation to Environmental Gradients
Steppe, P., Rey-Bedón, C., Kumar, S., Forrest, E., Wagt, N. V. D., Tayal, A., Tsimring, L. S., & Hasty, J. (2024) · ACS Synthetic Biology · doi:10.1021/acssynbio.3c00617 · Cited by 1
Self-citationE. Coli Nissle 1917 Based Carrier for DNA Delivery into Colorectal Carcinoma Cells
Deeb, N. E., Otinov, G. D., Mohamed, A.-A., Gandalipov, E. R., Kovtunov, E. A., & Koshel, E. I. (2024) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162024110451 · Cited by 1
Programmable cancer treatments: Engineering biology approaches for living cures
Biarnes-Carrera, M., Sevko, A., Glanville, N., & Deban, L. (2024) · Engineering Biology · doi:10.1049/enb2.12032 · Cited by 1
Biomimetic Nucleic Acid Drug Delivery Systems for Relieving Tumor Immunosuppressive Microenvironment
Yan, W., Cao, Y., Yin, Q., & Li, Y. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16081028 · Cited by 1
A Microrobotic System Based on Engineered Bacteria for Targeted Self‐Driven Photodynamic Therapy
Jin, K., Yu, L., Zhang, Y., Niu, L., Huang, Y. B., Zhang, Y., & Wu, Y. (2024) · Angewandte Chemie · doi:10.1002/ange.202414347 · Cited by 1
Stationary-Phase Antimicrobial Peptide Production in Escherichia coli
Yu, W.-S., Chen, M., Ting, C.-L., Tsung, W.-H., Sun, P., Liu, P., & Li, S. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10517-2 · Cited by 1
Development of ultrasound-visualized tumor-targeting engineered bacteria for precise tumor therapy
Li, Q., Chi, Z., Zou, Z., Zhou, Y., & Ye, B. (2025) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2025.03.009 · Cited by 3
Application of bacteria-mediated gene therapy in tumor treatment
Feng, R., Du, M., & Chen, Z. (2025) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2025.2502638 · Cited by 3
A pleiotropic regulator AtrA undergoes liquid-liquid phase separation in regulating quorum sensing
Ma, B., Hu, X., Sun, C., Xie, J., Luo, Y., Wang, B., Feng, Y., Jiang, H., Zhao, Q., & Mao, X. (2025) · 中国科学通报:英文版 · doi:10.1016/j.scib.2025.09.013 · Cited by 1
Cytrynbaum, E. G., & McClean, M. N. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115740 · Cited by 1
The application of AI-driven and engineered intratumoral microbes in cancer therapy
Guo, Y., Yu, R., Wang, Z., Chang, J., & Han, L. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07546-4 · Cited by 4
Dangi, S., Liew, D. S., Subramaniyan, V., & Narayanan, K. (2026) · Microbial Cell Factories · doi:10.1186/s12934-026-02944-9 · Cited by 1
Ha, J., & Song, M. (2026) · Scientific Reports · doi:10.1038/s41598-026-44265-2 · Cited by 2
Gubran, A. N. M., & Khalifa, M. A. (2026) · The Microbe · doi:10.1016/j.microb.2026.100700 · Cited by 2
Use of in vitro co-culture models to inform bacterial engineering for the treatment of solid tumours
Foschini, S., Wright, J. A., Woods, S. L., & de Nys, R. (2026) · npj Biomedical Innovations. · doi:10.1038/s44385-026-00075-9 · Cited by 1
Wu, L.-Y., Qiu, J.-H., Qiao, X.-Y., Li, L. Z., Qiao, L.-Y., Li, C.-Y., Sun, Y., Zhang, S.-H., Du, Z.-Z., Chang, X.-Y., et al. (2026) · Military Medical Research · doi:10.1016/j.mmr.2026.100030 · Cited by 4
Sonoimmunology in cancer therapy: expanding crosstalk among ultrasound-materials-immune system
Liu, Z., Wu, P., & Yuan, L. (2026) · Materials & Design · doi:10.1016/j.matdes.2026.116179 · Cited by 1
Deng, Y., Liang, H., Wan, A. H., Liu, C., Yan, S., Li, J., Xiao, M., Zhou, Q., Liu, R., Zhang, Z., et al. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102801 · Cited by 2
Immunomodulatory microbials for cancer immunotherapy: A mini review
Hou, Y., Shi, Y., & Yang, Y. (2026) · Chinese Chemical Letters · doi:10.1016/j.cclet.2026.112912 · Cited by 1
Programmable living therapeutics for cancer immunotherapy
Deng, Z., Niu, L., Wang, Z., Jin, Y., Yao, Z., Wan, H., Guan, N., & Ye, H. (2026) · Cell chemical biology · doi:10.1016/j.chembiol.2026.04.007 · Cited by 5
Geng, F., Yue, L., Du, M., Jin, J., Zhang, Q., Hu, W., Hao, N., Liu, S., Jiang, P., & Pan, X. (2026) · Biotechnology Journal · doi:10.1002/biot.70243 · Cited by 1
Engineering quorum sensing: new directions for antimicrobial therapy
Urbauer, E., Gräwe, A., Chamas, A., & Papenfort, K. (2026) · Trends in Microbiology · doi:10.1016/j.tim.2026.05.006 · Cited by 1
Bacterial engineering for cancer therapy
Chen, N., Yang, Z., & Arpaia, N. (2026) · Nature Cancer · doi:10.1038/s43018-026-01171-w · Cited by 4
Jeon, K., Kim, U., Ji, C.-H., Kamaraj, M., Laird, N. Z., Wang, Z., Yu, H., Ermis, M., Sullan, R. M. A., Shen, X., et al. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103330 · Cited by 1
Saikia, T., Das, S., Rajak, P., & Kalita, J. M. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117032 · Cited by 1
Engineering Bacteria for Medicine: Delivery, Diagnosis, and Therapy
Xia, S., Fu, G., Ding, X., Yang, W., Bai, R., Cai, Y., Zhang, J. X., Wei, Y., Han, C., Gao, Y., et al. (2026) · iMetaMed · doi:10.1002/imm3.70046 · Cited by 3
Progress in engineered bacterial cancer therapies
Pico-Sánchez, E., & Fernández, L. Á. (2026) · Current Opinion in Microbiology · doi:10.1016/j.mib.2026.102785 · Cited by 2
Nomiri, S., Yazdani, F., Heidary, H., Sadeghi, A., Tarzemani, S., Sadeghloo, Z., Niasar, M. S., Tillotson, G., Safarpour, H., & Raeisi, H. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-11164-x · Cited by 1
Guha, L., Malik, J. A., & Bose, B. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115274 · Cited by 1
Engineered probiotics for tumor-targeted combination chemoimmunotherapy
Yang, Z., Im, J., Chen, N., Mariuzza, D. L., Santos, K. D. L., Li, F., Ballister, E. R., Ringham, O. R., Danino, T., & Arpaia, N. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.ady2289 · Cited by 2
Self-citationBiosynthesis and application of magnetosomes in tumor-targeting therapy
Zhang, Y., Li, A., Fu, J. F., Zhong, L., & Li, X. (2017) · Scientia Sinica Vitae · doi:10.1360/n052017-00066
Theranostic Approaches Using Live Bacteria
Min, J., Duong, M. T.-Q., Thangam, R., You, S.-H., & Kang, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-816386-3.00056-9 · Cited by 1
Ultrasound-activated bacteria with thermostat controls as living therapeutics
Chen, F., Zeng, W., & Wegner, S. V. (2022) · Matter · doi:10.1016/j.matt.2022.05.014 · Cited by 1
Coordinated microbial lysis bursts into the drug delivery scene
Sen, S., & Kunjapur, A. M. (2023) · Trends in biotechnology · doi:10.1016/j.tibtech.2023.01.010 · Cited by 1
Blue‐Purple evaluation: Chromoproteins facilitate the identification of BioBrick compatibility
Ba, F., Zhang, Y., Wang, L., Liu, W., & Li, J. (2024) · Biotechnology and Bioengineering · doi:10.1002/bit.28862 · Cited by 1
Yoo, S. W., Kim, H.-S., Min, J., & Lee, C. (2019) · Endoscopic Microscopy · doi:10.1117/12.2509530 · Cited by 1
Combination of versatile platforms for the development of synthetic biology
Chen, B., & Dai, Z. (2020) · Quantitative Biology · doi:10.1007/s40484-020-0197-2 · Cited by 1
Genetically engineered microbes for sustainable therapies
Sharma, A. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820528-0.00009-0 · Cited by 1
Dynamical behaviors of quorum sensing network mediated by combinatorial perturbation
Chen, M., Liu, H., & Wang, R. (2022) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2022225 · Cited by 1
Leaman, E. J. (2016) · VTechWorks (Virginia Tech) · Cited by 2
Bacterial cell lysis: geometry, elasticity, and implicationsPreprint
Wong, F. J., & Amir, A. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/343350 · Cited by 1
Engineering Self-Organized Criticality in Living CellsPreprint
Vidiella, B., Guillamon, A., Sardanyés, J., Maull, V., Conde, N., & Solé, R. V. (2020) · Preprints.org · doi:10.20944/preprints202011.0546.v1 · Cited by 1
Lezia, A., Csicsery, N., & Hasty, J. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.22.449269 · Cited by 1
Self-citationEngineered E. coli for the Targeted Deposition of Therapeutic Payloads to Sites of DiseasePreprint
Lynch, J. P., González-Prieto, C., Reeves, A. Z., Powale, U., Godbole, N. P., Tremblay, J. M., Schmidt, F. I., Ploegh, H. L., Glickman, J. N., Leong, J. M., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4133893 · Cited by 2
Editorial: Microbiota and metabolites in cancer immunotherapy
Roviello, G., & Catalano, M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1093941 · Cited by 1
Nguyen, N. T., Wang, M., Li, L., & Chan, C. T. Y. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.16.628630 · Cited by 1
Design of a Modular Inducible Circuit for Pulsatile Population Control of Engineered BacteriaPreprint
Roy, R., & Mayalu, M. N. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.03.652077 · Cited by 1
Implantable Living Materials Autonomously Deliver Therapeutics from Contained Engineered BacteriaPreprint
Harimoto, T., Quevedo, F., Zillig, J., Schreiber, S., Wu, Y. X., Ahn, C. H., To, T., Thakur, R., Tatara, A. M., Kang, S. J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.09.681377 · Cited by 1
Engineering tumor-homing bacteria as membrane-anchored immune checkpoint-blockade interfacesPreprint
Wang, Z., Fang, C., Zhou, X., Yang, S., Shah, Y. M., Romee, R., Moon, J. J., & Li, J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.10.731477 · Cited by 1
Voliotis, M., & Liverpool, T. B. (2017) · Journal of Statistical Mechanics Theory and Experiment · doi:10.1088/1742-5468/aa58ad
Kotsuka, T., & Hori, Y. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/304436
Singh, R., & Gupta, S. (2018) · Therapeutic Delivery · doi:10.4155/tde-2018-0010
Characterisation and development of aspirin inducible biosensors in E. coli Nissle 1917 and SimCellsPreprint
Chen, J. X., Steel, H., Wu, Y.-H., Wang, Y., Xu, J., Rampley, C. P. N., Thompson, I. P., Papachristodoulou, A., & Huang, W. E. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/414169
Engineered phenotype patterns in microbial populationsPreprint
Bittihn, P., Didovyk, A., Tsimring, L. S., & Hasty, J. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/575068
Self-citationBermudes, D. G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11362-5
Nora, L. C. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2019.tde-30052019-165948
Engineering microbial peer pressure
Johnston, C. W., & Collins, J. J. (2019) · Science · doi:10.1126/science.aay3157
Semidefinite programming for Turing instability analysis in molecular communication networks
Hori, Y., & Miyazako, H. (2019) · IEEE Conference on Decision and Control (CDC) · doi:10.1109/cdc40024.2019.9029976
Meyer, D. (2020) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7949 · Cited by 1
Finite number fluctuations in a three-state model with growing population
Moy, T., Pinto, Í. L. D., & Rosas, A. (2020) · Physica A Statistical Mechanics and its Applications · doi:10.1016/j.physa.2020.124745
Gomes, K. R. D. S. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2020.tde-18082020-213357
Electrolysis of selectively patterned Vorticella with pneumatic microchambers and electrodes
Nagai, M., KOHARA, R., Santra, T. S., & Shibata, T. (2020) · Mechanical Engineering Journal · doi:10.1299/mej.20-00254
Biological patterning in networks of interacting cells
Perkins, M. L. (2020) · eScholarship (California Digital Library) · Cited by 1
Wang, L., Huang, J., Yang, S., Huang, S., & Li, N. (2020) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2020-0457 · Cited by 1
Brain Rhythm Fluctuations: Envelope-Phase Modeling and Phase Synchronization
Powanwe, A. S. (2021) · uO Research (University of Ottawa) · doi:10.20381/ruor-26338
AIDS: Women and Girls Bear the Burden in Zimbabwe
Machipisa, L. (2002)
In vitro reconstituted quorum sensing pathways enable rapid evaluation of quorum sensing inhibitorsPreprint
Yu, D. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.29.466404
TANIZAKI, K., Santra, T. S., Shibata, T., & Nagai, M. (2021) · Mechanical Engineering Journal · doi:10.1299/mej.21-00199
小野寺, 清., 明吉, 智., & 徳光, 雅. (2002) · 電子情報通信学会ソサイエティ大会講演論文集
Metadata
- Authors
- Din, M. O., Danino, T., Prindle, A., Skalak, M., Selimkhanov, J., Allen, K., Julio, E., Atolia, E., Tsimring, L. S., Bhatia, S. N., & Hasty, J.
- Affiliations
- University of California San Diego (US)
- Massachusetts Institute of Technology (US)
- Broad Institute (US)
- Corresponding author
- Hasty, Jeff
- ORCID
- Venue
- Nature
- Published
- 2016-07-20
- Volume
- 536
- Issue
- 7614
- Pages
- 81-85
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5048415
- OpenAlex
- W2480697384
- Cited by
- 784
- References
- 31
- Citations by year
- 2026: 97 · 2025: 107 · 2024: 95 · 2023: 87 · 2022: 73 · 2021: 71 · 2020: 82 · 2019: 59 · 2018: 55 · 2017: 43 · 2016: 12
- FWCI
- 49.00
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
- PMC
- Funders
- Howard Hughes Medical Institute
- University of California, San Diego
- National Cancer Institute (K99CA197649, R00CA197649, DP1CA174420, P30CA014051)
- National Institute of General Medical Sciences (P50GM085764, R01GM069811)
- National Institute of Environmental Health Sciences (P30ES002109)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Keywords
- bacterial lysis, quorum sensing, synthetic biology, Salmonella, pulsatile drug delivery, cancer therapy, colorectal cancer, liver metastasis, bacterial population dynamics, luminescent reporter, combination chemotherapy, oral administration, living therapeutics
- MeSH terms
- Administration, Oral, Animals, Bacteriolysis, Computer Simulation, Female, Liver Neoplasms, Neoplasm Metastasis, Neoplasm Transplantation, Salmonella, Transplantation, Isogeneic, Colorectal Neoplasms, Drug Delivery Systems, Coculture Techniques, Luminescence, Mice, Quorum Sensing, Synthetic Biology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.